GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Formycon AG (XTER:FYB) » Definitions » Pre-Tax Income

Formycon AG (XTER:FYB) Pre-Tax Income : €79.07 Mil (TTM As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Formycon AG Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Formycon AG's pretax income for the six months ended in Dec. 2023 was €70.01 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was €79.07 Mil. Formycon AG's pretax margin was 206.47%.

During the past 13 years, Formycon AG's highest Pretax Margin was 101.77%. The lowest was -38.80%. And the median was -1.01%.


Formycon AG Pre-Tax Income Historical Data

The historical data trend for Formycon AG's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Formycon AG Pre-Tax Income Chart

Formycon AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.30 -6.64 -14.21 36.60 79.07

Formycon AG Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.60 80.05 -43.45 9.06 70.01

Competitive Comparison of Formycon AG's Pre-Tax Income

For the Biotechnology subindustry, Formycon AG's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Formycon AG's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Formycon AG's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Formycon AG's Pre-Tax Income falls into.



Formycon AG Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Formycon AG's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-0.369+0+-0.08+2.817+76.702
=79.07

Formycon AG's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-6.727+0+-0.041+2.431+74.344
=70.01

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €79.07 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Formycon AG  (XTER:FYB) Pre-Tax Income Explanation

Formycon AG's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=70.007/33.907
=206.47%

During the past 13 years, Formycon AG's highest Pretax Margin was 101.77%. The lowest was -38.80%. And the median was -1.01%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Formycon AG Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Formycon AG's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Formycon AG (XTER:FYB) Business Description

Traded in Other Exchanges
Address
Fraunhoferstrasse 15, Martinsried, Planegg, BY, DEU, 82152
Formycon AG is a pharmaceutical company. It is engaged in the development of pharmaceutical and biopharmaceutical products and the development of drug delivery systems. Its focus is on treatments in ophthalmology and immunology as well as other chronic diseases. The company's pipeline in the biosimilar drugs category includes FYB201, FYB202, FYB203, and FYB207 for the treatment of COVID 19. It is also engaged in the provision of diagnostic laboratory services and works for third parties and the carrying out of diagnostic laboratory services.
Executives
Dr. Stefan Glombitza Board of Directors
Dr. Carsten Brockmeyer Board of Directors
Dr. Nicolas Combé Board of Directors

Formycon AG (XTER:FYB) Headlines

No Headlines